During the past decade, CHWAPI conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 3 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHWAPI" #1 sponsor was "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 3 trials, followed by "The Lymphoma Academic Research Organisation" with 3 trials sponsored, "Medicrea International" with 2 trials sponsored, "AEterna Zentaris" with 1 trials sponsored and "AZ-VUB" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHWAPI" #1 collaborator was "CHU de Nancy" with 1 trials as a collaborator, "Central European Myeloma Study Group" with 1 trials as a collaborator, "ClinStat GmbH" with 1 trials as a collaborator, "DSMM (Deutsche Studiengruppe Multiples Myelom)" with 1 trials as a collaborator and "European Myeloma Network" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "CHWAPI" are "Breast Cancer" (2 trials), "Advanced or Metastatic Renal Cell Carcinoma" (1 trials), "C-CURVE , Cervical Interbody Cage" (1 trials), "COVID-19" (1 trials) and "Cancer of Endometrium" (1 trials). Many other conditions were trialed in "CHWAPI" in a lesser frequency.

Most popular intervention types in "CHWAPI" are "Drug" (13 trials), "Biological" (3 trials), "Device" (3 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Convalescent Plasma" (2 trials), "Cyclophosphamide" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials) and "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHWAPI" are 18 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "CHWAPI". undefined are not yet recruiting, 4 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in CHWAPI, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CHWAPI, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".

CHWAPI has several departments that took part in Clinical trials: "RHMS TournayService de néphrologie" - 4 trials